David H Stitelman

Title: David H. Stitelman: Innovator in Fetal Medicine

Introduction

David H. Stitelman is a notable inventor based in Branford, Connecticut. He has made significant contributions to the field of fetal medicine through his innovative research and patents. His work focuses on the delivery of active agents to fetuses, which has the potential to improve prenatal care.

Latest Patents

Stitelman holds a patent for "Compositions and methods for in utero delivery." This patent describes compositions and methods for the fetal or in utero delivery of active agents. The compositions are typically administered intravenously via the vitelline vein, umbilical vein, or directly into the amniotic cavity of a pregnant mother. One of the key components of his research involves using fibroblast growth factor to correct structural defects of neural tissue. He has 1 patent to his name.

Career Highlights

David H. Stitelman is affiliated with Yale University, where he continues to advance his research in fetal medicine. His work has garnered attention for its potential to enhance the health outcomes of unborn children.

Collaborations

Some of his notable coworkers include W. Mark Saltzman and James Stephen Farrelly. Their collaborative efforts contribute to the innovative research being conducted at Yale University.

Conclusion

David H. Stitelman is a pioneering inventor whose work in fetal medicine is making a significant impact. His innovative approaches to in utero delivery are paving the way for advancements in prenatal care.